Pay in 4 interest-free payments of $27.50 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
MAP2K1/2/3/4/6/7
is an orally bioavailable inhibitor of cyclin-dependent kinases (CDKs) and thropomyosin receptor kinase A (TRKA)
5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28
Synthesis and anticancer activity of polyhydroxylated 18-membered analogue of antimycin A3
(2015) Science
EPI-001 - CAS# 227947-06-0 Size:10mg solid MAP2K1/2/3/4/6/7EPI 001, a selective inhibitor of Androgen Receptor (AR), targets transactivation unit 5 (Tau 5) of the AR. EPI 001 can inhibit transactivation of the AR amino terminal domain (NTD), with an IC50 of ~6 M. EPI 001 is also a selective modulator of PPAR. EPI 001 is active against castration resistant prostate cancer. Product information CAS Number: 227947 06 0 Molecular Weight: 394. 89 Formula: C21H27ClO5 Chemical Name: 3 (4 {2 [4 (3 chloro 2
US$ 138.66
US$ 124.75
US$ 135.45
US$ 40.00
US$ 150.00
US$ 127.61
US$ 160.00
US$ 170.38
US$ 131.53
US$ 192.50